SC Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies that deactivate mechano-sensitive ion channels (MSCs) to treat respiratory and cardiovascular disease, today reports ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...

Think its just a lingering cough An expert explains the hidden early signs of asthma that often mimic a cold or allergies ...

Dr Saurabh Sethi and Dr (Brig.) Pankaj Puri explains why you shouldn't ignore the throat-clearing habit. Here is why it could ...

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Life expectancy rose from the age of 30 to nearly 80 years. Today, infectious diseases have given way to chronic conditions ...

Today is World Bronchiectasis Day, an observance to raise awareness about a lesser-known chronic lung disease that affects ...

Zymeworks, a biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of ...

For decades, lung disease has been the most visible and life-threatening part of cystic fibrosis. People might picture ...

A new form of interactive web symposium that turns doctors' vivid questions and concerns from the clinical front line into ...

We all know someone with that dreaded cough. The one that lingers for months. The one that gets brushed off as a smoker’s cough, winter bugs, getting older, or just […] ...

The renal cancer pipeline presents key opportunities in developing novel therapies targeting immunosuppression and oncogenic pathways. Notable advancements include combinations like Quavonlimab with ...